Jeffery J. Auletta, MD :: Nationwide Children's Hospital, Columbus, Ohio

Contact Information

Hematology & Oncology
700 Children's Dr
Columbus, OH 43205 [ map ]
PH: (614) 722-3550
FX: (614) 722-3369

Location Information for Patients

Main Campus

Biography

Dr. Auletta is the Director of the Blood and Marrow Transplant (BMT) Program and the Host Defense and Immunocompromised Infectious Diseases (HD) Program at Nationwide Children's Hospital. He is a physician in both Hematology/Oncology/BMT and Infectious Diseases at Nationwide Children’s Hospital. Dr. Auletta is an associate professor of Pediatrics at The Ohio State University College of Medicine. He is a member of the Leukemia Research Program at The NCI-designated Ohio State University Comprehensive Cancer Center and a member of the Center for Regenerative Medicine and Cell-based Therapies at The Ohio State University. Dr. Auletta completed his internship and residency in Pediatrics and his fellowships in both Pediatric Hematology-Oncology and Pediatric Infectious Diseases at University Hospitals and Case Medical Center/Rainbow Babies & Children’s Hospital. He earned his doctor of medicine from Case Western Reserve University School of Medicine and his bachelor of arts from Northwestern University. Dr. Auletta is a member of several professional organizations, including the Children’s Oncology Group (COG), the American Society for Blood and Marrow Transplantation (ASBMT), the Pediatric Infectious Diseases Society (PIDS) and the Infectious Diseases Society of America (IDSA). He is Co-Chair for the Infection and Immune Reconstitution Working Committee of the Center for International Blood & Marrow Transplant Research (CIBMTR) and for the Supportive Care Committee of the Pediatric Blood and Marrow Transplant Consortium (PBMTC).

Gender:

  • Male

Languages Spoken:

  • English

Education and Training

Medical School

  • Case Western Reserve University
    Date Completed: 06/30/1996

Residency

  • University Hospitals Case Medical Center
    Date Completed: 06/30/1999

Fellowship

  • University Hospitals Case Medical Center
    Date Completed: 06/30/2003

Fellowship

  • University Hospitals of Cleveland
    Date Completed: 06/30/2003

Department:

  • Pediatrics

Section:

  • Hematology & Oncology

Specialty:

  • Pediatric Hematology Oncology
  • Pediatric Infectious Diseases
  • Pediatrics

Date of Appointment at Nationwide Children’s Hospital:

  • 12/03/2012

Publications

  • Ballen,Karen; Ahn,Kwang,Woo; Chen,Min; Abdel-Azim,Hisham; Ahmed,Ibrahim; Aljurf,Mahmoud; Antin,Joseph; Bhatt,Ami,S; Boeckh,Michael; Chen,George; Dandoy,Christopher; George,Biju; Laughlin,Mary,J; Lazarus,Hillard,M; MacMillan,Margaret,L; Margolis,David,A; Marks,David,I; Norkin,Maxim; Rosenthal,Joseph; Saad,Ayman; Savani,Bipin; Schouten,Harry,C; Storek,Jan; Szabolcs,Paul; Ustun,Celalettin; Verneris,Michael,R; Waller,Edmund,K; Weisdorf,Daniel,J; Williams,Kirsten,M; Wingard,John,R; Wirk,Baldeep; Wolfs,Tom; Young,Jo-Anne,H; Auletta,Jeffrey; Komanduri,Krishna,V; Lindemans,Caroline; Riches,Marcie,L. 2016. Infection Rates among Acute Leukemia Patients Receiving Alternative Donor Hematopoietic Cell Transplantation.  BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. Vol. 22, no. 9. (September): 1636-1645.
  • Ramanathan,M; Teira,P; Battiwalla,M; Barrett,J; Ahn,K,W; Chen,M; Green,J; Laughlin,M; Lazarus,H,M; Marks,D; Saad,A; Seftel,M; Saber,W; Savani,B; Waller,E,K; Wingard,J; Auletta,J,J; Lindemans,C,A; Boeckh,M; Riches,M,L. 2016. Impact of early CMV reactivation in cord blood stem cell recipients in the current era.  Bone marrow transplantation. Vol. 51, no. 8. (August): 1113-1120.
  • Teira,Pierre; Battiwalla,Minoo; Ramanathan,Muthalagu; Barrett,A,John; Ahn,Kwang,Woo; Chen,Min; Green,Jaime,S; Saad,Ayman; Antin,Joseph,H; Savani,Bipin,N; Lazarus,Hillard,M; Seftel,Matthew; Saber,Wael; Marks,David; Aljurf,Mahmoud; Norkin,Maxim; Wingard,John,R; Lindemans,Caroline,A; Boeckh,Michael; Riches,Marcie,L; Auletta,Jeffery,J. 2016. Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis.  BLOOD. Vol. 127, no. 20. (May): 2427-2438.
  • Williams,K,M; Ahn,K,W; Chen,M; Aljurf,M,D; Agwu,A,L; Chen,A,R; Walsh,T,J; Szabolcs,P; Boeckh,M,J; Auletta,J,J; Lindemans,C,A; Zanis-neto,J; Malvezzi,M; Lister,J; de Toledo Codina,J,S; Sackey,K; Chakrabarty,J,LH; Ljungman,P; Wingard,J,R; Seftel,M,D; Seo,S; Hale,G,A; Wirk,B; Smith,M,S; Savani,B,N; Lazarus,H,M; Marks,D,I; Ustun,C; Abdel-Azim,H; Dvorak,C,C; Szer,J; Storek,J; Yong,A; Riches,M,R. 2016. The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic cell transplantation: a CIBMTR analysis.  BONE MARROW TRANSPLANTATION. Vol. 51, no. 4. (April): 573-580.
  • Vasu,Sumithira; Geyer,Susan; Bingman,Anissa; Auletta,Jeffery,J; Jaglowski,Samantha; Elder,Pat; Donnell,Lynn,O; Bradbury,Hillary; Kitzler,Rhonda; Andritsos,Leslie; Blum,William; Klisovic,Rebecca; Penza,Sam; Efebera,Yvonne; Hofmeister,Craig; Benson,Don,M; Muthusamy,Natarajan; Lozanski,Gerard; Devine,Steven,M. 2016. Granulocyte Colony-Stimulating Factor Mobilized Allografts Contain Activated Immune Cell Subsets Associated with Risk of Acute and Chronic Graft-versus-Host Disease.  BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. Vol. 22, no. 4. (April): 658-668.
  • Auletta,J,J; Devine,S,M; Waller,E,K. 2016. Plasmacytoid dendritic cells in allogeneic hematopoietic cell transplantation: benefit or burden?.  BONE MARROW TRANSPLANTATION. Vol. 51, no. 3. (March): 333-343.
  • Naples,J,C; Skeens,M,A; Auletta,J; Rangarajan,H; Abu-Arja,R; Horwitz,E; Stanek,J; Bajwa,R,S. 2016. Anicteric veno-occlusive disease after hematopoietic stem cell transplantation in children.  BONE MARROW TRANSPLANTATION. Vol. 51, no. 1. (January): 135-137.
  • Burke,Michael,J; Verneris,Michael,R; Le Rademacher,Jennifer; He,Wensheng; Abdel-Azim,Hisham; Abraham,Allistair,A; Auletta,Jeffery,J; Ayas,Mouhab; Brown,Valerie,I; Cairo,Mitchell,S; Chan,Ka,Wah; Diaz Perez,Miguel,A; Dvorak,Christopher,C; Egeler,R,Maarten; Eldjerou,Lamis; Frangoul,Haydar; Guilcher,Gregory,MT; Hayashi,Robert,J; Ibrahim,Ahmed; Kasow,Kimberly,A; Leung,Wing,H; Olsson,Richard,F; Pulsipher,Michael,A; Shah,Niketa; Shah,Nirali,N; Thiel,Elizabeth; Talano,Julie-An; Kitko,Carrie,L. 2015. Transplant Outcomes for Children with T Cell Acute Lymphoblastic Leukemia in Second Remission: A Report from the Center for International Blood and Marrow Transplant Research.  BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. Vol. 21, no. 12. (December): 2154-2159.
  • Abu-Arja,Rolla,F; Chernin,Leah,R; Abusin,Ghada; Auletta,Jeffery; Cabral,Linda; Egler,Rachel; Ochs,Hans,D; Torgerson,Troy,R; Lopez-Guisa,Jesus; Hostoffer,Robert,W; Tcheurekdjian,Haig; Cooke,Kenneth,R. 2015. Successful hematopoietic cell transplantation in a patient with X-linked agammaglobulinemia and acute myeloid leukemia.  PEDIATRIC BLOOD & CANCER. Vol. 62, no. 9. (September): 1674-1676.
  • Auletta,Jeffery,J; Eid,Saada,K; Wuttisarnwattana,Patiwet; Silva,Ines; Metheny,Leland; Keller,Matthew,D; Guardia-Wolff,Rocio; Liu,Chen; Wang,Fangjing; Bowen,Theodore; Lee,Zhenghong; Solchaga,Luis,A; Ganguly,Sudipto; Tyler,Megan; Wilson,David,L; Cooke,Kenneth,R. 2015. Human Mesenchymal Stromal Cells Attenuate Graft-Versus-Host Disease and Maintain Graft-Versus-Leukemia Activity Following Experimental Allogeneic Bone Marrow Transplantation.  STEM CELLS. Vol. 33, no. 2. (February): 601-614.
  • Gonzalez B, Cabral L, Auletta JJ. 2015. Febrile Neutropenia. In Supportive Care in Pediatric Oncology. Edited by Feusner J, Hastings C, Agrawal AK. New York: Springer Berlin Heidelberg.
  • Wang,Fangjing; Eid,Saada; Dennis,James,E; Cooke,Kenneth,R; Auletta,Jeffery,J; Lee,Zhenghong. 2015. Route of delivery influences biodistribution of human bone marrow-derived mesenchymal stromal cells following experimental bone marrow transplantation.  Journal of stem cells & regenerative medicine. Vol. 11, no. 2. (January): 34-43.
  • Abu-Arja,R,F; Gonzalez,B,E; Jacobs,M,R; Cabral,L; EGLER,R; Auletta,J; Arnold,J; Cooke,K,R. 2014. Disseminated Bacillus Calmette-Guerin (BCG) infection following allogeneic hematopoietic stem cell transplant in a patient with Bare Lymphocyte Syndrome type II.  TRANSPLANT INFECTIOUS DISEASE. Vol. 16, no. 5. (October): 830-837.
  • Petrosiute,Agne; Auletta,Jeffery,J; Lazarus,Hillard,M. 2012. Achieving graft-versus-tumor effect in brain tumor patients: from autologous progenitor cell transplant to active immunotherapy.  IMMUNOTHERAPY. Vol. 4, no. 11. (November): 1139-1151.
  • Auletta,Jeffery,J; Bartholomew,Amelia,M; Maziarz,Richard,T; Deans,Robert,J; Miller,Robert,H; Lazarus,Hillard,M; Cohen,Jeffrey,A. 2012. The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis.  IMMUNOTHERAPY. Vol. 4, no. 5. (May): 529-547.
  • Auletta,Jeffery,J; Deans,Robert,J; Bartholomew,Amelia,M. 2012. Emerging roles for multipotent, bone marrow-derived stromal cells in host defense.  BLOOD. Vol. 119, no. 8. (February): 1801-1809.
  • Auletta,Jeffery,J; Zale,Elizabeth,A; Welter,Jean,F; Solchaga,Luis,A. 2011. Fibroblast Growth Factor-2 Enhances Expansion of Human Bone Marrow-Derived Mesenchymal Stromal Cells without Diminishing Their Immunosuppressive Potential.  Stem cells international. Vol. 2011, no. March: 235176-?.
  • Auletta,Jeffery,J; Zale,Elizabeth,A; Welter,Jean,F; Solchaga,Luis,A. 2011. Fibroblast Growth Factor-2 Enhances Expansion of Human Bone Marrow-Derived Mesenchymal Stromal Cells without Diminishing Their Immunosuppressive Potential.  STEM CELLS INTERNATIONAL. Vol. Mar 3, no. January: e235176.
  • Auletta JJ. 2010. The Immune Response to Fungal Challenge. In The Immune respopnse o fungal challenge. Edited by Perfect J, Ghannoum M.. New York: Informal Healthcare.
  • Carlson,Eric,C; Sun,Yan; Auletta,Jeffery; Kao,Winston,WY; Liu,Chia-Yang; Perez,Victor,L; Pearlman,Eric. 2010. Regulation of corneal inflammation by neutrophil-dependent cleavage of keratan sulfate proteoglycans as a model for breakdown of the chemokine gradient.  JOURNAL OF LEUKOCYTE BIOLOGY. Vol. 88, no. 3. (September): 517-522.
  • Auletta,Jeffery,J; Cooke,Kenneth,R; Solchaga,Luis,A; Deans,Robert,J; van't Hof,Wouter. 2010. Regenerative Stromal Cell Therapy in Allogeneic Hematopoietic Stem Cell Transplantation: Current Impact and Future Directions.  BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. Vol. 16, no. 7. (July): 891-906.
  • Auletta,Jeffery,J; Cooke,Kenneth,R. 2009. Bone marrow transplantation: new approaches to immunosuppression and management of acute graft-versus-host disease.  CURRENT OPINION IN PEDIATRICS. Vol. 21, no. 1. (February): 30-38.
  • Auletta,J,J; Lazarus,H,M. 2005. Immune restoration following hematopoietic stem cell transplantation: an evolving target.  BONE MARROW TRANSPLANTATION. Vol. 35, no. 9. (May): 835-857.
  • Maziarz RT, Brazauskas B, Chen M, McLeod AA, Martino R, Wingard JR, Aljurf M, Battiwalla M, Dvorak CC, Geroge B, Guinan EC, Hale GA, Lazarus HM, Leee JW, Liesveld JL, Ramanathan M, Redy V, Savani BN, Smith FO, Strasfeld L, Taplitz Ra, Ustun C, Boeckh MJ, Gea-Banacloche J, Lindemans CA, Auletta JJ, Riches ML. 0. Pre-Existing invasive fungal 8infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies: a CIBMTR study.  Bone Marrow Transplant.
  • Teira P, Battiwalla M, Ramanathan M, Barrett AJ, Ahn K, Chen M, Green J, Saad A, Antin JH, Savani BN, Lazarus HM, Seftel M, Saber W, Marks D, Aljurf M, Norkin M, Wingard JR, Lindemans CA, Boeckh M, Riches ML, Auletta JJ. 0. Early CMV reactivation increases transplant-related mortality without attenuating hematologic disease relapse risk following allogeneic hematopoietic cell transplantation: a CIBMTR study.  Blood.
  • Dvorak, CC, Auletta, JJ. Fever and Infection in the Immunocompromised Patient.
  • Ramanathan M, Teira P, Battiwalla M, Barrett J, Ahn K, Chen M, Green J, Saad A, Seftel M, Saber W, Svani B, Waller E, Wingard JR, Auletta JJ, Lindemans CA, Boeckh M, Riches ML. 0. Impact of early cytomegaloviru8s reactivation in cor blood stem cell recipents in the current era.  Bone Marrow Transplant.

featured video

Transforming Care for our Sickest Kids: Meet Dr. Auletta
Nationwide Children's Hospital
700 Children's Drive Columbus, Ohio 43205 614.722.2000